Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spine Asia CoROCO:6758 80 OCF Margin % is 10.93% as of Dec. 2025, which is 40% above its 10-year median of 7.81. GuruFocus rates ROCO:6758 with a GF Score™ of 80/100 and a GF Value™ of NT$48.62 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Spine Asia Co ranks better than 51.16% on this metric.
The historical rank and industry rank for Spine Asia Co's OCF Margin % or its related term are showing as below:
ROCO:6758'
s OCF Margin % Range Over the Past 10 Years
Min: 1.01 Med: 7.81 Max: 11.29
Current: 6.63
During the past 10 years, the highest OCF Margin % of Spine Asia Co was 11.29%. The lowest was 1.01%. And the median was 7.81%.
ROCO:6758's OCF Margin % is ranked better than 51.16% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs ROCO:6758: 6.63
Spine Asia Co OCF Margin % Related Terms
Spine Asia Co OCF Margin % Historical Data
* Premium members only.
The historical data trend for Spine Asia Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6758 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Spine Asia Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spine Asia Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Spine Asia Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Spine Asia Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Spine Asia Co (ROCO:6758) has a OCF Margin % of 10.93% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Spine Asia Co and its competitors. This is 40% above median its historical median of 7.81. Over the past decade, Spine Asia Co's OCF Margin % has ranged from 1.01 to 11.29. According to the industry distribution chart, Spine Asia Co ranks #399 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 48.8%.
Is Spine Asia Co's OCF Margin % too high?
Spine Asia Co's current OCF Margin % of 10.93% is 40% above median its 10-year median of 7.81. Over the past 10 years, this metric has ranged from a low of 1.01 to a high of 11.29. The Medical Devices & Instruments industry median OCF Margin % is 5.82. Spine Asia Co's value of 10.93% is 87.8% above this industry median. Based on the distribution chart, Spine Asia Co ranks #399 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Spine Asia Co has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spine Asia Co's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Spine Asia Co ranks #399 out of 817 companies for OCF Margin %. This puts Spine Asia Co in the upper half of its industry. The industry median OCF Margin % is 5.82. Spine Asia Co's value of 10.93% is 87.8% above this benchmark. Historically, Spine Asia Co's own OCF Margin % has ranged from 1.01 to 11.29 over the past decade. While the company's 10-year median is 7.81 vs. the industry median of 5.82, Spine Asia Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spine Asia Co's current OCF Margin % of 10.93% is 87.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Spine Asia Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spine Asia Co's current OCF Margin % is 10.93%, which is 40% above median its own 10-year median of 7.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spine Asia Co stock overvalued right now?
Based on GuruFocus' analysis, Spine Asia Co (ROCO:6758) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$48.62, compared to a current price of NT$29.25 — trading 39.8% below its estimated fair value. The current OCF Margin % is 10.93%, which is 40% above median its 10-year median of 7.81 and 87.8% above the Medical Devices & Instruments industry median of 5.82. Spine Asia Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Spine Asia Co (ROCO:6758), the current OCF Margin % is 10.93% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spine Asia Co (ROCO:6758) Overvalued in 2026?
Based on GuruFocus' analysis, Spine Asia Co stock appears to be undervalued.
The current stock price of NT$29.25 is trading 39.8% below its estimated GF Value™ of NT$48.62.
GuruFocus considers Spine Asia Co to be Significantly Undervalued.
Key valuation signals for ROCO:6758:
OCF Margin %: 10.93% (40% above median its 10-year median of 7.81)
GF Value™: NT$48.62 vs. price of NT$29.25 (39.8% below fair value)
Industry Position: 87.8% above the Medical Devices & Instruments median (#399 of 817)
No single metric tells the full story. See the ROCO:6758 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spine Asia Co Ltd is a medical device company. It is engaged in the research, development, manufacturing, and marketing of spinal, implants and instruments. The company offers products such as vigor lumbar peek cage, remond polymer cervical cage, and combo cervical disc cage.
80GF Score
Get the complete analysis for ROCO:6758
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6758 has been successfully added to your 
